RARA CRAFT DATABASE for FDA Medical Devices

FDA Device Decisions, October 2025: Cryoablation for Low-Risk Breast Cancer, Home Fetal Ultrasound and Four De Novo Grants

日本語版

One of FDA's four De Novo grants in October 2025 went to the ProSense Cryoablation System (DEN220077), which treats breast cancer by freezing it. It is indicated for patients 70 and older with biologically low-risk tumors of 1.5 cm or smaller who receive adjuvant endocrine therapy, including patients not suitable for surgery.

The classification's special controls include postmarket surveillance: a study of 400 patients tracking same-breast recurrence for up to five years. The same month, FDA also granted a De Novo for an ultrasound system that pregnant women use at home so that clinicians can check the fetal heart rate.

Counting records held in RA Craft Database (decisions through August 31, 2026, tallied October 6), FDA cleared 304 510(k)s in October 2025, granted 4 De Novo requests and approved 1 original PMA. These counts have not been reconciled with FDA's own figures. The site holds 510(k), De Novo and PMA records from 2015 onward, and counts for past months can change as the data are updated.

Counts by pathway

October 2025 next to the previous month and the same month a year earlier, with records assigned to a month by FDA decision date.

PathwayOctober 2025September 2025October 2024
510(k)304257292
De Novo436
PMA (original)146
PMA supplement226197220

Records held in RA Craft Database, decisions through August 31, 2026.

510(k) clearances were 47 more than in September and above October 2024 (292). There were 4 De Novo grants and 1 original PMA.

The busiest product codes

October's 510(k)s spread across 179 product codes. GEX (powered laser surgical instrument) led with 12, followed by GEI (electrosurgical, cutting & coagulation & accessories) and QIH (automated radiological image processing software) with 8 each, and LLZ (system, image processing, radiological) and NHA (abutment, implant, dental, endosseous) with 7 each. A single 510(k) can carry more than one product code, so per-code counts can add up to more than the number of submissions. If your code is on the list, enter it in the Product Code field on Search to see the records sorted by decision date.

De Novo: four classifications, one of them Class I

October's four De Novo grants, with the classification names and regulation numbers from each Classification Order:

  • ProSense Cryoablation System (DEN220077, IceCure Medical): Cryoablation device for local treatment of low-risk breast cancer (21 CFR 878.4355), Class II
  • PainChek Adult (DEN240073, PainChek Limited): Pain assessment software in non-communicative adults (21 CFR 882.1472), Class II
  • Modius Lean (DEN240076, Neurovalens Limited): Cranial electrotherapy stimulator for weight management (21 CFR 876.5984), Class I
  • Pulsenmore ES (DEN240074, Pulsenmore, Ltd.): Ultrasound imaging system for acquiring images at home by lay users (21 CFR 892.1590), Class II

"21 CFR" refers to Title 21 of the Code of Federal Regulations, where FDA's regulations are codified.

PainChek Adult helps doctors, nurses, nursing assistants and other trained staff assess pain in non-verbal nursing home residents with moderate to severe dementia. Modius Lean is a home-use device that applies electrical current to the head to support weight management alongside diet and exercise in adults with a BMI of 27 or more; it was placed in Class I and exempted from 510(k).

Original PMAs: one approval

  • Access HBsAg (P230015, Beckman Coulter, Inc.): a chemiluminescent immunoassay for hepatitis B surface antigen, approved together with its confirmatory assay, calibrator and quality control materials (product code LOM)

October also brought 226 PMA supplements, which cover changes to already approved PMA devices among other things.

Three devices worth a closer read

1. ProSense Cryoablation System (DEN220077, De Novo). Local treatment of breast cancer by freezing rather than surgical removal, limited to small, low-risk tumors in patients 70 and older. Its nine special controls cover clinical performance testing and postmarket surveillance, software verification, sterility and more, and the labeling must address training and ice-ball sizing. The postmarket study follows 400 patients at about 30 sites for ipsilateral breast tumor recurrence for up to five years, with enrollment milestones.

2. Pulsenmore ES (DEN240074, De Novo). Pregnant women with a singleton pregnancy at 14 to 38 weeks capture ultrasound images at home, on a physician's order, so that clinicians can determine the fetal heart rate; scanning is guided either by a clinician over telehealth or by the app. Its ten special controls include design features that limit the number and duration of scans, a training program to be completed before the first scan, and human factors testing. An imaging device in lay hands is controlled through limits on how it can be used.

3. Modius Lean (DEN240076, De Novo). A prescription home-use device that applies a low current, not intended to induce a seizure, through skin electrodes on the head. FDA set no special controls, found general controls sufficient, placed the device type in Class I and exempted it from 510(k). Devices of the same type can now go to market without a 510(k), within the limits of the exemption.

Compare the three devices

Open DEN220077, DEN240074 and DEN240076, star (☆) each one, tick "Compare" on all three in My Workspace and press "3 selected for comparison". The comparison table puts their Indications for Use side by side. Before relying on any of this, open "FDA Record" and "Summary PDF" on each record and read the source.

Note: months are assigned by FDA decision date, and counts can change as the data are updated each month.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles